Effects of contraceptives on hemoglobin and ferritin

H. Bathija, Z. W. Lei, X. Q. Cheng, L. Xie, Y. Wang, S. Rugpao, S. Lipisam, C. Suwanarach, Halida Akhter, Y. Ahmed, Z. Islam, A. Sen, S. Bahman, S. A. Khan, A. Rabbani, T. Khan, E. M. Sued, P. Lumbiganon, Y. Weerawattrakul, P. PinitsoontornH. Bierschwale, P. Silva, C. Bravo, R. Gajardo, N. Meta, F. Lavin, R. Tuane, E. Chong, S. Hajri, N. Siala, M. Bessioud, R. Boukhris

Research output: Contribution to journalArticle

Abstract

The effects of combined oral contraceptives (OC), depot medroxyprogesterone acetate injections (DMPA), levonorgestrel subdermal implant (Norplant®), copper-containing intrauterine devices (copper IUD), and Chinese stainless steel ring IUD on hemoglobin and ferritin were studied in 18-40-year-old, nonpregnant, and nonlactating women in seven countries (Bangladesh, Chile, China, the Dominican Republic, Pakistan, Thailand, and Tunisia). Data from 2507 women were analyzed. The study had a cross- sectional component in which 1295 current users of the contraceptive methods were compared with 1212 women initiating use of contraceptives. The results of this component showed that the current users of hormonal contraceptive methods generally had higher hemoglobin and ferritin levels than the noncontraceptors. The differences between women using hormonal contraceptive and noncontraceptots in mean values for hemoglobin varied between 3 and 6 g/L and for ferritin between 2 and 18 g/L. The current users of copper IUD had higher hemoglobin levels (difference in mean levels of 3 g/L), but lower ferritin levels (difference of 10 g/L) than noncontraceptors. Current use of the stainless steel ring had an adverse effect on both hemoglobin and ferritin. In a longitudinal component of the study, 285 anemic women (hemoglobin between 80 and 120 g/L at the time of initiation of contraception) - a subgroup of the cross-sectional component - were followed- up at 3, 6, and 12 months after initiation. In this component, significant mean increases of hemoglobin at 12 months were observed among the users of oral contraceptives and DMPA, but not among users of copper or stainless steel ring IUD. It is concluded that hemoglobin and ferritin levels are influenced by the use of contraceptives and that the hormonal contraceptives included in the present study have a beneficial effect on these parameters the effects of copper IUD on hemoglobin and ferritin should be studied further.

Original languageEnglish (US)
Pages (from-to)261-273
Number of pages13
JournalContraception
Volume58
Issue number5
DOIs
StatePublished - Nov 1 1998
Externally publishedYes

Fingerprint

Ferritins
Contraceptive Agents
Hemoglobins
Copper Intrauterine Devices
Stainless Steel
Contraception
Apoferritins
Levonorgestrel
Medroxyprogesterone Acetate
Dominican Republic
Contraceptives, Oral, Combined
Tunisia
Injections
Bangladesh
Chile
Pakistan
Thailand
Oral Contraceptives
Longitudinal Studies
Copper

Keywords

  • Anemia
  • Copper intrauterine device
  • Depot medroxyprogesterone acetate (DMPA)
  • Ferritin
  • Hemoglobin
  • Norplant® implants
  • Oral contraceptives
  • Stainless steel intrauterine device

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Bathija, H., Lei, Z. W., Cheng, X. Q., Xie, L., Wang, Y., Rugpao, S., ... Boukhris, R. (1998). Effects of contraceptives on hemoglobin and ferritin. Contraception, 58(5), 261-273. https://doi.org/10.1016/S0010-7824(98)00108-5

Effects of contraceptives on hemoglobin and ferritin. / Bathija, H.; Lei, Z. W.; Cheng, X. Q.; Xie, L.; Wang, Y.; Rugpao, S.; Lipisam, S.; Suwanarach, C.; Akhter, Halida; Ahmed, Y.; Islam, Z.; Sen, A.; Bahman, S.; Khan, S. A.; Rabbani, A.; Khan, T.; Sued, E. M.; Lumbiganon, P.; Weerawattrakul, Y.; Pinitsoontorn, P.; Bierschwale, H.; Silva, P.; Bravo, C.; Gajardo, R.; Meta, N.; Lavin, F.; Tuane, R.; Chong, E.; Hajri, S.; Siala, N.; Bessioud, M.; Boukhris, R.

In: Contraception, Vol. 58, No. 5, 01.11.1998, p. 261-273.

Research output: Contribution to journalArticle

Bathija, H, Lei, ZW, Cheng, XQ, Xie, L, Wang, Y, Rugpao, S, Lipisam, S, Suwanarach, C, Akhter, H, Ahmed, Y, Islam, Z, Sen, A, Bahman, S, Khan, SA, Rabbani, A, Khan, T, Sued, EM, Lumbiganon, P, Weerawattrakul, Y, Pinitsoontorn, P, Bierschwale, H, Silva, P, Bravo, C, Gajardo, R, Meta, N, Lavin, F, Tuane, R, Chong, E, Hajri, S, Siala, N, Bessioud, M & Boukhris, R 1998, 'Effects of contraceptives on hemoglobin and ferritin', Contraception, vol. 58, no. 5, pp. 261-273. https://doi.org/10.1016/S0010-7824(98)00108-5
Bathija H, Lei ZW, Cheng XQ, Xie L, Wang Y, Rugpao S et al. Effects of contraceptives on hemoglobin and ferritin. Contraception. 1998 Nov 1;58(5):261-273. https://doi.org/10.1016/S0010-7824(98)00108-5
Bathija, H. ; Lei, Z. W. ; Cheng, X. Q. ; Xie, L. ; Wang, Y. ; Rugpao, S. ; Lipisam, S. ; Suwanarach, C. ; Akhter, Halida ; Ahmed, Y. ; Islam, Z. ; Sen, A. ; Bahman, S. ; Khan, S. A. ; Rabbani, A. ; Khan, T. ; Sued, E. M. ; Lumbiganon, P. ; Weerawattrakul, Y. ; Pinitsoontorn, P. ; Bierschwale, H. ; Silva, P. ; Bravo, C. ; Gajardo, R. ; Meta, N. ; Lavin, F. ; Tuane, R. ; Chong, E. ; Hajri, S. ; Siala, N. ; Bessioud, M. ; Boukhris, R. / Effects of contraceptives on hemoglobin and ferritin. In: Contraception. 1998 ; Vol. 58, No. 5. pp. 261-273.
@article{fac0d70ebaa9420b91a0a86de5f8c6cb,
title = "Effects of contraceptives on hemoglobin and ferritin",
abstract = "The effects of combined oral contraceptives (OC), depot medroxyprogesterone acetate injections (DMPA), levonorgestrel subdermal implant (Norplant{\circledR}), copper-containing intrauterine devices (copper IUD), and Chinese stainless steel ring IUD on hemoglobin and ferritin were studied in 18-40-year-old, nonpregnant, and nonlactating women in seven countries (Bangladesh, Chile, China, the Dominican Republic, Pakistan, Thailand, and Tunisia). Data from 2507 women were analyzed. The study had a cross- sectional component in which 1295 current users of the contraceptive methods were compared with 1212 women initiating use of contraceptives. The results of this component showed that the current users of hormonal contraceptive methods generally had higher hemoglobin and ferritin levels than the noncontraceptors. The differences between women using hormonal contraceptive and noncontraceptots in mean values for hemoglobin varied between 3 and 6 g/L and for ferritin between 2 and 18 g/L. The current users of copper IUD had higher hemoglobin levels (difference in mean levels of 3 g/L), but lower ferritin levels (difference of 10 g/L) than noncontraceptors. Current use of the stainless steel ring had an adverse effect on both hemoglobin and ferritin. In a longitudinal component of the study, 285 anemic women (hemoglobin between 80 and 120 g/L at the time of initiation of contraception) - a subgroup of the cross-sectional component - were followed- up at 3, 6, and 12 months after initiation. In this component, significant mean increases of hemoglobin at 12 months were observed among the users of oral contraceptives and DMPA, but not among users of copper or stainless steel ring IUD. It is concluded that hemoglobin and ferritin levels are influenced by the use of contraceptives and that the hormonal contraceptives included in the present study have a beneficial effect on these parameters the effects of copper IUD on hemoglobin and ferritin should be studied further.",
keywords = "Anemia, Copper intrauterine device, Depot medroxyprogesterone acetate (DMPA), Ferritin, Hemoglobin, Norplant{\circledR} implants, Oral contraceptives, Stainless steel intrauterine device",
author = "H. Bathija and Lei, {Z. W.} and Cheng, {X. Q.} and L. Xie and Y. Wang and S. Rugpao and S. Lipisam and C. Suwanarach and Halida Akhter and Y. Ahmed and Z. Islam and A. Sen and S. Bahman and Khan, {S. A.} and A. Rabbani and T. Khan and Sued, {E. M.} and P. Lumbiganon and Y. Weerawattrakul and P. Pinitsoontorn and H. Bierschwale and P. Silva and C. Bravo and R. Gajardo and N. Meta and F. Lavin and R. Tuane and E. Chong and S. Hajri and N. Siala and M. Bessioud and R. Boukhris",
year = "1998",
month = "11",
day = "1",
doi = "10.1016/S0010-7824(98)00108-5",
language = "English (US)",
volume = "58",
pages = "261--273",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Effects of contraceptives on hemoglobin and ferritin

AU - Bathija, H.

AU - Lei, Z. W.

AU - Cheng, X. Q.

AU - Xie, L.

AU - Wang, Y.

AU - Rugpao, S.

AU - Lipisam, S.

AU - Suwanarach, C.

AU - Akhter, Halida

AU - Ahmed, Y.

AU - Islam, Z.

AU - Sen, A.

AU - Bahman, S.

AU - Khan, S. A.

AU - Rabbani, A.

AU - Khan, T.

AU - Sued, E. M.

AU - Lumbiganon, P.

AU - Weerawattrakul, Y.

AU - Pinitsoontorn, P.

AU - Bierschwale, H.

AU - Silva, P.

AU - Bravo, C.

AU - Gajardo, R.

AU - Meta, N.

AU - Lavin, F.

AU - Tuane, R.

AU - Chong, E.

AU - Hajri, S.

AU - Siala, N.

AU - Bessioud, M.

AU - Boukhris, R.

PY - 1998/11/1

Y1 - 1998/11/1

N2 - The effects of combined oral contraceptives (OC), depot medroxyprogesterone acetate injections (DMPA), levonorgestrel subdermal implant (Norplant®), copper-containing intrauterine devices (copper IUD), and Chinese stainless steel ring IUD on hemoglobin and ferritin were studied in 18-40-year-old, nonpregnant, and nonlactating women in seven countries (Bangladesh, Chile, China, the Dominican Republic, Pakistan, Thailand, and Tunisia). Data from 2507 women were analyzed. The study had a cross- sectional component in which 1295 current users of the contraceptive methods were compared with 1212 women initiating use of contraceptives. The results of this component showed that the current users of hormonal contraceptive methods generally had higher hemoglobin and ferritin levels than the noncontraceptors. The differences between women using hormonal contraceptive and noncontraceptots in mean values for hemoglobin varied between 3 and 6 g/L and for ferritin between 2 and 18 g/L. The current users of copper IUD had higher hemoglobin levels (difference in mean levels of 3 g/L), but lower ferritin levels (difference of 10 g/L) than noncontraceptors. Current use of the stainless steel ring had an adverse effect on both hemoglobin and ferritin. In a longitudinal component of the study, 285 anemic women (hemoglobin between 80 and 120 g/L at the time of initiation of contraception) - a subgroup of the cross-sectional component - were followed- up at 3, 6, and 12 months after initiation. In this component, significant mean increases of hemoglobin at 12 months were observed among the users of oral contraceptives and DMPA, but not among users of copper or stainless steel ring IUD. It is concluded that hemoglobin and ferritin levels are influenced by the use of contraceptives and that the hormonal contraceptives included in the present study have a beneficial effect on these parameters the effects of copper IUD on hemoglobin and ferritin should be studied further.

AB - The effects of combined oral contraceptives (OC), depot medroxyprogesterone acetate injections (DMPA), levonorgestrel subdermal implant (Norplant®), copper-containing intrauterine devices (copper IUD), and Chinese stainless steel ring IUD on hemoglobin and ferritin were studied in 18-40-year-old, nonpregnant, and nonlactating women in seven countries (Bangladesh, Chile, China, the Dominican Republic, Pakistan, Thailand, and Tunisia). Data from 2507 women were analyzed. The study had a cross- sectional component in which 1295 current users of the contraceptive methods were compared with 1212 women initiating use of contraceptives. The results of this component showed that the current users of hormonal contraceptive methods generally had higher hemoglobin and ferritin levels than the noncontraceptors. The differences between women using hormonal contraceptive and noncontraceptots in mean values for hemoglobin varied between 3 and 6 g/L and for ferritin between 2 and 18 g/L. The current users of copper IUD had higher hemoglobin levels (difference in mean levels of 3 g/L), but lower ferritin levels (difference of 10 g/L) than noncontraceptors. Current use of the stainless steel ring had an adverse effect on both hemoglobin and ferritin. In a longitudinal component of the study, 285 anemic women (hemoglobin between 80 and 120 g/L at the time of initiation of contraception) - a subgroup of the cross-sectional component - were followed- up at 3, 6, and 12 months after initiation. In this component, significant mean increases of hemoglobin at 12 months were observed among the users of oral contraceptives and DMPA, but not among users of copper or stainless steel ring IUD. It is concluded that hemoglobin and ferritin levels are influenced by the use of contraceptives and that the hormonal contraceptives included in the present study have a beneficial effect on these parameters the effects of copper IUD on hemoglobin and ferritin should be studied further.

KW - Anemia

KW - Copper intrauterine device

KW - Depot medroxyprogesterone acetate (DMPA)

KW - Ferritin

KW - Hemoglobin

KW - Norplant® implants

KW - Oral contraceptives

KW - Stainless steel intrauterine device

UR - http://www.scopus.com/inward/record.url?scp=0032412251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032412251&partnerID=8YFLogxK

U2 - 10.1016/S0010-7824(98)00108-5

DO - 10.1016/S0010-7824(98)00108-5

M3 - Article

AN - SCOPUS:0032412251

VL - 58

SP - 261

EP - 273

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -